Retinoids for vulvar dysplasia in the HIV-infected patient.
Del Priore
G
G
Division of Gynecologic Oncology, New York University School of Medicine, USA. gyn.oncology@ccmail.med.nyu.edu
Herron
M M
MM
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002278:Carcinoma in Situ / Q000150:complications / Q000188:drug therapy / Q000601:surgery; D003131:Combined Modality Therapy; D005260:Female; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D009361:Neoplasm Invasiveness; D009364:Neoplasm Recurrence, Local / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D014212:Tretinoin / Q000627:therapeutic use*; D002583:Uterine Cervical Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D014625:Vaginal Neoplasms / Q000150:complications; D014846:Vulvar Neoplasms / Q000150:complications / Q000188:drug therapy*; D002578:Uterine Cervical Dysplasia / Q000150:complications / Q000188:drug therapy* / Q000601:surgery
D000970:Antineoplastic Agents; D014212:Tretinoin